SQUAWK/NEWS
Menu
Live News EQUITY L impact

DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bun

DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation

DYAI

DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation